Cargando…
New Approaches to Immunotherapy for HPV Associated Cancers
Cervical cancer is the second most common cancer of women worldwide and is the first cancer shown to be entirely induced by a virus, the human papillomavirus (HPV, major oncogenic genotypes HPV-16 and -18). Two recently developed prophylactic cervical cancer vaccines, using virus-like particles (VLP...
Autores principales: | Bergot, Anne-Sophie, Kassianos, Andrew, Frazer, Ian H, Mittal, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759206/ https://www.ncbi.nlm.nih.gov/pubmed/24212964 http://dx.doi.org/10.3390/cancers3033461 |
Ejemplares similares
-
Immunotherapy for HPV associated cancer
por: Frazer, Ian H., et al.
Publicado: (2019) -
HPV16-E7 Expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions
por: Bergot, Anne-Sophie, et al.
Publicado: (2015) -
Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
por: Julian, Ricklie, et al.
Publicado: (2021) -
HPV16-E7 Expression in Squamous Epithelium Creates a Local Immune Suppressive Environment via CCL2- and CCL5- Mediated Recruitment of Mast Cells
por: Bergot, Anne-Sophie, et al.
Publicado: (2014) -
Indoleamine 2,3-dioxygenase Activity Contributes to Local Immune Suppression in the
Skin Expressing Human Papillomavirus Oncoprotein E7
por: Mittal, D, et al.
Publicado: (2013)